2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¾ÖÅÍ¹Ì HemoHIM, ÇǷΰ³¼±¡¤¸é¿ª·Â °­È­ ÀÌÁß ±â´É¼º ÀÎÁ¤ (2024-02-03)
¿øµÎÄ¿ÇÇ Àü¹®±â¾÷ Àðµ­, Ȩ¼îÇÎ ½ÃÀå ÁøÃâ (2016-01-01)
³²ºÏû¼Ò³âÁß¾Ó¿¬¸Í, 2024³â û¼Ò³â ÅëÀÏ´í½º °æ¿¬´ëȸ (2024-06-15)
÷´Ü¼ÒÀç ÀÎÀçÀ°¼º ÀåÇÐ±Ý 68¸í¿¡ Áö¿ø (2023-12-16)
G2 Risk Solutions Unveils Revolutionary, Single-platform Sol... (2024-08-30)
Successful completion of World Invention Creativity Olympics... (2023-08-02)
Faraday Partnered with SONIX to Create a New Product Featuri... (2024-03-28)
âÀÇÀûÀ̰í ȹ±âÀûÀÎ AI ½º¸¶Æ®ÀüÀÚ¹ßÀü±âAISEG (2023-12-13)
Quectel Introduces Versatile BG95-S5 NTN Satellite Communica... (2024-04-16)
KOTRA-Çѱ¹¼öÀÚ¿ø°ø»ç, ¡®¹° »ê¾÷¡¯ ÇØ¿ÜÁøÃâ ¼ÕÀâ´Â´Ù (2023-09-17)
°¡Á¤ÀÇ ´Þ ¼±¹°, ·¹µåÆäÀ̽º ÀçŶ ¾î¶§¿ä (2024-05-05)
ÇÑÈ­±×·ì, »ç¸·È­ ¹æÁö žçÀÇ ½£ 6È£ Á¶¼º (2016-09-02)
»ó½ÂÀÌ³Ä Ãß¶ôÀÌ³Ä ÇÏ¹Ý±â ½Â±Þ ½É»ç ¾ÕµÎ°í, °æ·û¼±¼ö ¼Ó ź´Ù (2015-06-03)
YG PLUS, ¾ÆÇÁ¸®Ä« Áö¿ªÀ¸·Î ÄÜÅÙÃ÷ °ø±Þ È®´ë (2024-07-20)
Á¶Àμº, ìí µµÄì ÆÒ¹ÌÆÃ¿¡ ÀÌ¾î ¿À»çÄ« °ø¿¬ (2024-07-20)
³ó½É, ¸ÔűøÅ«»ç¹ß¸é¡¤Æ÷Å×ÅäĨ ¸ÔÅÂû¾ç¸¶¿ä¸À Ãâ½Ã (2024-01-28)
2~3¿ù ¿­±³È¯±â•ž籤•dz·Â•¹è°ü µî ±³À°»ý ... (2024-01-28)
LabGenomics USA Concludes Acquisition of IMD CLIA Labs (2024-11-03)
¡®¾Æ¸óµå Ç÷§È­ÀÌÆ®¡¯ ¹× ¡®¿ÀÆ® Ç÷§È­ÀÌÆ®¡¯ ĸ½¶ (2022-10-31)
Á¤È­Á¶¿¡¼­ Àá¼ö¸¦?¡¦±Ø¾ÇÀÇ ÇØ¿Ü ÀÌ»ö ¾Ë¹Ù (2016-01-30)
27°³±¹ ÄÚÀÌÄ« ±Û·Î¹ú ¼­Æ÷Åͽº È­·ÁÇÑ Çdz¯·¹ ¼î (2023-12-10)
Ãִ뼺, ½Å°î ¡®´©³ª »ç¶ûÇØ¡¯ ¹ßÇ¥ (2023-07-27)
Æ÷½ºÄÚÀÎÅͳ»¼Å³Î-GSĮŨ½º, ÆÊÀ¯ Á¤Á¦»ç¾÷ °øµ¿ ÃßÁø (2023-10-22)
¹Ì´Ï½¬Å×Å©³î·ÎÁö, º£Æ®³² µ§Å»½ÃÀå ÁøÃâ (2024-04-13)
À¥Äɽñ۷ιú, º£Æ®³² ½ÃÀå °ø·« °­È­ (2023-11-29)
       [ÀÌÀü][1]....[747][748][749][750][751][752][753][754][755]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..